American Society of Clinical Oncology--46th annual meeting.
The 46th Annual Meeting of the American Society of Clinical Oncology, held in Chicago, included topics covering new therapeutic developments in the field of oncology. This conference report highlights selected presentations on novel therapies for cancers including glioblastoma, breast cancer, myeloma, NSCLC and solid tumors. Investigational drugs discussed include rindopepimut and PF-299804 (both Pfizer Inc), entinostat (Syndax Pharmaceuticals Inc), panobinostat and NVP-LDE-225 (both Novartis AG), CHR-3996 (Chroma Therapeutics Ltd), and HGS-1029 (Human Genome Sciences Inc).
Al-Shamahi
Asma
A
Thomson Reuters, London, UK. asma.al-shamahi@thomsonreuters.com
Murch
Lisa
L
Kirkham
Konrad
K
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015195:Drug Design; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D015507:Drugs, Investigational